LMAT Logo

LeMaitre Vascular, Inc. (LMAT) 

NASDAQ
Market Cap
$2.29B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
606 of 776
Rank in Industry
38 of 48

Largest Insider Buys in Sector

LMAT Stock Price History Chart

LMAT Stock Performance

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the …

Insider Activity of LeMaitre Vascular, Inc.

Over the last 12 months, insiders at LeMaitre Vascular, Inc. have bought $0 and sold $41.35M worth of LeMaitre Vascular, Inc. stock.

On average, over the past 5 years, insiders at LeMaitre Vascular, Inc. have bought $209,078 and sold $24.7M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 30 shares for transaction amount of $932 was made by Roush John A (director) on 2020‑08‑26.

List of Insider Buy and Sell Transactions, LeMaitre Vascular, Inc.

2024-08-13SalePresident and Director
3,063
0.0137%
$82.07$251,3800.00%
2024-08-05SaleSenior V. P., Operations
182
0.0008%
$81.82$14,891+11.46%
2024-07-16SaleChairman and CEO
57,372
0.2706%
$86.69$4.97M+2.10%
2024-07-15SaleChairman and CEO
27,030
0.1269%
$86.27$2.33M0.00%
2024-07-12SaleChairman and CEO
12,976
0.0608%
$86.07$1.12M0.00%
2024-05-16Saledirector
5,500
0.0244%
$77.99$428,945+11.48%
2024-05-14SaleChairman and CEO
40,968
0.1805%
$76.80$3.15M+10.89%
2024-05-13SaleChairman and CEO
35,826
0.1608%
$76.42$2.74M+13.40%
2024-05-08SaleChairman and CEO
8,000
0.036%
$75.30$602,427+15.05%
2024-05-07SaleChairman and CEO
26,044
0.117%
$75.24$1.96M+13.76%
2024-05-07SaleChairman and CEO
46,300
0.2087%
$75.51$3.5M+13.76%
2024-05-06SaleChairman and CEO
68,906
0.3113%
$75.70$5.22M+14.99%
2024-05-06SalePresident and Director
5,025
0.0227%
$75.62$379,991+14.99%
2024-03-08SaleSenior V. P., Operations
4,542
0.0205%
$68.18$309,684+19.48%
2024-03-07Saledirector
7,500
0.0339%
$69.00$517,500+16.91%
2024-03-05Saledirector
5,110
0.0229%
$67.50$344,925+18.90%
2024-03-04SaleChairman and CEO
36,600
0.1643%
$68.03$2.49M+18.01%
2024-03-01SaleChairman and CEO
37,019
0.1667%
$67.85$2.51M+18.57%
2024-02-29SaleChairman and CEO
27,859
0.1248%
$69.73$1.94M+14.37%
2024-02-29SaleChief Financial Officer
36,967
0.1657%
$69.77$2.58M+14.37%

Insider Historical Profitability

16.76%
LeMaitre George WChairman and CEO
1900956
8.4604%
$101.8417200+14.05%
Roberts David BPresident and Director
14114
0.0628%
$101.84181+68.49%
Pellegrino Joseph P JRChief Financial Officer
6452
0.0287%
$101.84140
Roush John Adirector
2278
0.0101%
$101.8426+51.72%
LeMaitre Cornelia Wdirector
178319
0.7936%
$101.843106<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$222.56M14.943.35M+1.72%+$3.75M0.01
Conestoga Capital Advisors, LLC$128.27M8.611.93M+0.26%+$328,216.541.89
The Vanguard Group$103.11M6.921.55M+0.32%+$329,411.04<0.01
Copeland Capital Management LLC$85.66M5.751.29M+2.46%+$2.05M1.56
Geneva Capital Management LLC$59.73M4.01900,038-0.52%-$310,963.031.05
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.